Treatment of small cell lung cancer in the elderly

Hematology/Oncology Clinics of North America

Volumn 18, Issue 2, 2004, Pages 433-443

  Jeremic, Branislav ^a   Zimmermann, Frank B ^a   Bamberg, Michael ^b   Molls, Michael ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; METHOTREXATE; PLATINUM; VINCRISTINE; VINDESINE;

ALOPECIA; ANEMIA; CANCER THERAPY; CARDIOTOXICITY; CLINICAL TRIAL; DIARRHEA; DISEASE ACTIVITY; DISEASE SEVERITY; ESOPHAGITIS; FEVER; HEMATOLOGIC DISEASE; HEMOPTYSIS; HUMAN; INFECTION; LEUKOPENIA; LUNG SMALL CELL CANCER; LUNG TOXICITY; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 1942535216     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2003.12.003     Document Type: Review

References (40)

1. Pignon J.P., Arriagada R., Ihde D.C.et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 327:1992;1618-1624.
2. Warde P., Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 10:1992;890-895.
3. Auperin A., Arriagada R., Pignon J.P.et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 341:1999;476-484.
4. Findlay M.P., Griffin A.M., Raghavan D.et al. Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means? Eur J Cancer. 27:1991;1597-1601.
5. Siu L., Shepherd F.A., Murray N.et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol. 14:1996;821-828.
6. Dajczman E., Fu L.Y., Small D.et al. Treatment of small cell lung carcinoma in the elderly. Cancer. 77:1996;2032-2038.
7. Nou E. Full chemotherapy in elderly patients with small cell bronchial carcinoma. Acta Oncol. 35:1996;399-406.
8. Jara C., Gomez-Aldaravi J.L., Tirado R.et al. Small-cell lung cancer in the elderly - is age of patient a relevant factor? Acta Oncol. 38:1999;781-786.
9. Yuen A.R., Zou G., Turrisi A.T.et al. Similar outcome of elderly patients in intergroup trial 0096: cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer. 89:2000;1953-1960.
10. Ludbrok J.J.S., Truong P.T., MacNeil M.V.et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys. 55:2003;1321-1330.
11. Joss R.A., Bacchi M., Hurny C.et al. Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol. 6:1995;157-166.
12. Jeremic B., Shibamoto Y., Acimovic L.et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol. 15:1997;893-900.
13. Jeremic B., Shibamoto Y., Acimovic L.et al. Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study. Cancer. 82:1998;836-841.
14. Murray N., Grafton C., Shah A.et al. Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer. J Clin Oncol. 16:1998;3323-3328.
15. Matsui K., Masuda N., Fukuoka M.et al. Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer. Br J Cancer. 77:1998;1961-1965.
16. Tebbutt N.C., Snyder R.D., Burns W.I. An analysis of the outcomes of treatment of small cell lung cancer in the elderly. Aust N Z J Med. 27:1997;160-164.
17. Kelly P., O'Brien A.A., Daly P.et al. Small-cell lung cancer in elderly patients: the case for chemotherapy. Age Ageing. 20:1991;19-22.
18. McKenna R.J. Sr. Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up. Cancer. 74:1994;2107-2117.
19. Montamat S.C., Cusack B.J., Vestal R.E. Management of drug therapy in the elderly. N Engl J Med. 321:1989;303-309.
20. Livingston R.B., Mira J.G., Chen T.T.et al. Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study. J Clin Oncol. 2:1984;585-590.
21. Jeremic B., Shibamoto Y., Nikolic N.et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol. 17:1999;2092-2099.
22. Murray N. Importance of dose and dose intensity in the treatment of small-cell lung cancer. Cancer Chemother Pharmacol. 40:1997;S58-S63.
23. Murray N., Livingston R.B., Shepherd F.A.et al. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol. 17:1999;2300-2308.
24. Beith J.M., Clarke S.J., Woods R.L.et al. Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung. Eur J Cancer. 32A:1996;438-443.
25. Shepherd F.A., Amdemichael E., Evans W.K.et al. Treatment of small cell lung cancer in the elderly. J Am Geriatr Soc. 42:1994;64-70.
26. Raghavan D., Bishop J.F., Stuart-Harris R.et al. Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderly. Semin Oncol. 19:1992;12-16.
27. Ohnoshi T., Ueoka H., Hino N.et al. Treatment of small cell lung cancer in the elderly: the progress and limitation of chemotherapy. Nihon Kyobu Shikkan Gakkai Zasshi. 30:1992;216-223.
28. Bishop J.F. Carboplatin/etoposide in small cell lung cancer. Oncology. 49:1992;111-117.
29. Quoix E.A., Giaccone G., Jassem J.et al. Epirubicin in previously untreated patients with small cell lung cancer: a phase II study by the EORTC Lung Cancer Cooperative Group. Eur J Cancer. 28A:1992;1667-1670.
30. Carney D.N., Grogan L., Smit E.F.et al. Single-agent oral etoposide for elderly small cell lung cancer patients. Semin Oncol. 17:1990;49-53.
31. Smit E.F., Carney D.N., Harford P.et al. A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax. 44:1989;631-633.
32. Medical Research Council Lung Cancer Working Party Comparison of oral etoposide and standard intravenous multi-drug chemotherapy for small-cell lung cancer: a stopped multicentre trial. Lancet. 348:1996;563-566.
33. Souhami R.L., Spiro S.G., Rudd R.M.et al. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst. 89:1997;577-580.
34. Byrne A., Carney D.N. Small cell lung cancer in the elderly. Semin Oncol. 21:1994;43-48.
35. Evans W.K., Radwi A., Tomiak E.et al. Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer. Am J Clin Oncol. 18:1995;149-155.
36. Larive S., Bombaron P., Riou R.et al. Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial. Lung Cancer. 35:2002;1-7.
37. Okamoto H., Watanabe K., Nishiwaki Y.et al. Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. J Clin Oncol. 17:1999;3540-3545.
38. Allen S.G., Gregor A., Cornbleet M.A.et al. Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol. 13:1984;106-108.
39. Medical Research Council Lung Cancer Working Party Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Br J Cancer. 73:1996;406-413.
40. Westeel V. New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen. J Clin Oncol. 16:1998;1940-1947.